Rite Aid up on Q2 results; updates fiscal 2020 guidance

Rite Aid (RAD) Q2 results: Revenues: $5366.3M (-1.0%); Retail Pharmacy Segment: $3,848.1M (-1.6%); Pharmacy Services Segment: $1,579.1M (1.1%).

Net Loss: ($78.7M) (+77.7%); Non-GAAP Net Income: $6.3M (+179.7%); loss/share: ($1.48) (+77.8%); Non-GAAP EPS: $0.12 (+180.0%); CF Ops: ($278.8M) (+2.0%).

FY 2020 guidance: Revenues: $21.5B – $21.9B (unch); net loss: ($235M) – ($275M) from ($170M) – ($220M); non-GAAP EPS: $0.00 – $0.56 from ($0.14) – $0.72; non-GAAP EBITDA: $510M – $550M from $500M – $560M; Capex: ~$250M (unch).

Shares are up 8% premarket.

Previously: Rite Aid EPS beats by $0.05, misses on revenue (Sept. 26)

https://seekingalpha.com/news/3501982-rite-aid-8-percent-q2-results-updates-fiscal-2020-guidance